Rosa Gini, PhD

Head of Department at Regional Health Agency of Tuscany, Florence, Italy
ARS Toscana, Florence, Italy
Florence, Toscana, Italy

N/A

AstraZeneca (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received, employed by ARS, a public research center participating in pharmacoepidemiology studies funded by public or private institutions and compliant with the ENCePP Code of Conduct. The budget of ARS is partially sustained by such studies.)Daiichi Sankyo (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received, I am employed by ARS, a public research center participating in pharmacoepidemiology studies funded by public or private institutions and compliant with the ENCePP Code of Conduct. The budget of ARS is partially sustained by such studies.)Eli Lilly (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received, I am employed by ARS, a public research center participating in pharmacoepidemiology studies funded by public or private institutions and compliant with the ENCePP Code of Conduct. The budget of ARS is partially sustained by such studies.)European Medicines Agency (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received, I am employed by ARS, a public research center participating in pharmacoepidemiology studies funded by public or private institutions and compliant with the ENCePP Code of Conduct. The budget of ARS is partially sustained by such studies.)Galapagos (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received, She is involved as investigators of observational studies funded by pharmaceutical companies (e.g Galapagos) in compliance with the ENCEPP code of conduct)Leo Pharma (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received, I am employed by ARS, a public research center participating in pharmacoepidemiology studies funded by public or private institutions and compliant with the ENCePP Code of Conduct. The budget of ARS is partially sustained by such studies.)Moderna (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received, I am employed by ARS, a public research center participating in pharmacoepidemiology studies funded by public or private institutions and compliant with the ENCePP Code of Conduct. The budget of ARS is partially sustained by such studies.)Novartis (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received, I am employed by ARS, a public research center participating in pharmacoepidemiology studies funded by public or private institutions and compliant with the ENCePP Code of Conduct. The budget of ARS is partially sustained by such studies.)Pfizer (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received, I am employed by ARS, a public research center participating in pharmacoepidemiology studies funded by public or private institutions and compliant with the ENCePP Code of Conduct. The budget of ARS is partially sustained by such studies.)

Presentation(s):

• Representing and Leveraging Heterogeneity Between Data Sources in Multi-database Pharmacoepidemiologic Studies

  Friday, August 26, 2022
  10:30 AM – 12:00 PM CEST

• Myocarditis and Pericarditis Associated with SARS-CoV-2 Vaccines in Four European Countries Using Large Electronic Health Care Data Sources: A Population-based Descriptive Cohort and a Nested Self-controlled Risk Interval Study

  Sunday, August 28, 2022
  1:45 PM – 2:00 PM CEST

• Triptan Consumption Before and After the Initiation of an Anti-CGRP mAb: A Descriptive Drug Utilization Study in Tuscany Region, Italy

  Sunday, August 28, 2022
  2:30 PM – 2:45 PM CEST

• Lightning Session 3

  Sunday, August 28, 2022
  1:30 PM – 3:00 PM CEST